Catalio Capital Management, LP 13F holdings, Q4 2025
Holdings as of December 31, 2025 · filings on SEC EDGAR · latest filing →
Catalio Capital Management, LP disclosed 45 US equity positions worth $565.8m in its Q4 2025 13F filing. The largest position was GILD at 6.3% of the reported book, followed by BMY and BSX. Against the Q3 2025 filing, it opened 14 new positions, added to 5 and reduced 20 among the top 45 holdings.
What did Catalio Capital Management, LP own in Q4 2025? Top 45 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2025 |
|---|---|---|---|---|---|---|---|
| 1 | GILD GILEAD SCIENCES INC | Healthcare | 6.3% | $35.5m | 289,312 | – | new |
| 2 | BMY BRISTOL-MYERS SQUIBB CO | Healthcare | 6.2% | $34.9m | 647,899 | – | new |
| 3 | BSX BOSTON SCIENTIFIC CORP | Healthcare | 6.1% | $34.4m | 360,428 | 37% | added |
| 4 | BBOT BRIDGEBIO ONCOLOGY THERAPEUT | 5.6% | $31.4m | 410,700 | – | new | |
| 5 | LLY ELI LILLY & CO | Healthcare | 4.9% | $27.9m | 25,923 | -55% | reduced |
| 6 | DNTH DIANTHUS THERAPEUTICS INC | Healthcare | 4.8% | $26.9m | 653,572 | -2% | reduced |
| 7 | ASND ASCENDIS PHARMA A/S | Healthcare | 4.5% | $25.4m | 119,265 | -18% | reduced |
| 8 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 4.4% | $25.1m | 1,196,807 | -26% | reduced |
| 9 | JNJ JOHNSON & JOHNSON | Healthcare | 4.4% | $25.0m | 120,840 | – | new |
| 10 | REGN REGENERON PHARMACEUTICALS | Healthcare | 4.1% | $23.0m | 29,797 | -16% | reduced |
| 11 | GPCR STRUCTURE THERAPEUTICS INC | Healthcare | 3.1% | $17.6m | 252,901 | -61% | reduced |
| 12 | SLNOEUR SOLENO THERAPEUTICS INC | 2.9% | $16.7m | 360,340 | -14% | reduced | |
| 13 | CYTK CYTOKINETICS INC | Healthcare | 2.9% | $16.4m | 258,381 | -43% | reduced |
| 14 | EW EDWARDS LIFESCIENCES CORP | Healthcare | 2.8% | $15.9m | 187,048 | – | new |
| 15 | ISRG INTUITIVE SURGICAL INC | Healthcare | 2.7% | $15.4m | 27,209 | -62% | reduced |
| 16 | NTRA NATERA INC | Healthcare | 2.5% | $14.3m | 62,273 | -58% | reduced |
| 17 | ADPT ADAPTIVE BIOTECHNOLOGIES COR | Healthcare | 2.4% | $13.3m | 821,195 | -7% | reduced |
| 18 | ABVX ABIVAX SA | 2.3% | $13.3m | 98,514 | -39% | reduced | |
| 19 | SUPN SUPERNUS PHARMACEUTICALS INC | Healthcare | 2.3% | $12.8m | 257,465 | -10% | reduced |
| 20 | GUTS FRACTYL HEALTH INC | 2.1% | $12.1m | 5,491,866 | 5% | added | |
| 21 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 2.1% | $12.0m | 331,849 | – | new |
| 22 | PHAT PHATHOM PHARMACEUTICALS INC | 2.0% | $11.6m | 698,996 | -38% | reduced | |
| 23 | ADMA ADMA BIOLOGICS INC | Healthcare | 1.8% | $10.3m | 564,461 | -18% | reduced |
| 24 | ACLXGBX ARCELLX INC | 1.8% | $10.2m | 156,109 | – | new | |
| 25 | DYN DYNE THERAPEUTICS INC | Healthcare | 1.8% | $10.2m | 519,715 | – | new |
| 26 | IRON DISC MEDICINE INC | Healthcare | 1.5% | $8.8m | 110,427 | -49% | reduced |
| 27 | OCUL OCULAR THERAPEUTIX INC | Healthcare | 1.5% | $8.7m | 714,501 | – | new |
| 28 | SEPN SEPTERNA INC | 1.5% | $8.2m | 294,360 | 0% | held | |
| 29 | TARA PROTARA THERAPEUTICS INC | 1.4% | $7.7m | 1,446,254 | -4% | reduced | |
| 30 | QURE UNIQURE NV | 1.2% | $6.9m | 288,345 | 2% | added | |
| 31 | OLMA OLEMA PHARMACEUTICALS INC | Healthcare | 1.2% | $6.7m | 267,058 | – | new |
| 32 | 430 TERNS PHARMACEUTICALS INC | 1.0% | $5.5m | 136,958 | – | new | |
| 33 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 0.7% | $3.7m | 162,550 | -44% | reduced |
| 34 | HTFL HEARTFLOW INC | Healthcare | 0.6% | $3.3m | 113,857 | – | new |
| 35 | GRAL GRAIL INC | 0.5% | $2.6m | 30,313 | -78% | reduced | |
| 36 | FULC FULCRUM THERAPEUTICS INC | Healthcare | 0.4% | $2.3m | 201,301 | – | new |
| 37 | BLLN BILLIONTOONE INC | 0.4% | $2.1m | 25,505 | – | new | |
| 38 | ELDN ELEDON PHARMACEUTICALS INC | 0.3% | $1.9m | 1,259,820 | 19% | added | |
| 39 | HYPR HYPERFINE INC | 0.2% | $1.3m | 1,320,041 | 93% | added | |
| 40 | PVLA PALVELLA THERAPEUTICS INC NE | 0.2% | $1.1m | 10,452 | -13% | reduced | |
| 41 | KPTI KARYOPHARM THERAPEUTICS INC | 0.2% | $1.1m | 142,984 | 0% | held | |
| 42 | MGX METAGENOMI INC | 0.2% | $857.0k | 528,993 | 0% | held | |
| 43 | ATAI BECKLEY NV | 0.1% | $805.1k | 196,858 | 0% | held | |
| 44 | OM OUTSET MED INC | 0.1% | $438.8k | 118,279 | 0% | held | |
| 45 | FTH SENSEI BIOTHERAPEUTICS INC | 0.0% | $157.0k | 14,718 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.